While individual results vary, most adults see measurable fat reduction when combining weekly injections with a medically supervised program
While there are no clinical trials specifically studying microdosed tirzepatide, anecdotal reports suggest it can be effective for some patients at lower total dose exposure
You may be a candidate if you: Have a BMI of 30 or higher, or 27+ with a weight-related condition Have struggled to maintain weight loss through diet and exercise alone Have prediabetes, type 2 diabetes, PCOS, or metabolic syndrome Do not have a personal or family history of medullary thyroid carcinoma or MEN2 Are not pregnant, breastfeeding, or planning pregnancy in the near term Have no history of pancreatitis or severe gastroparesis Your evaluation with Dr
First-Night of CPAP: Impact on Memory Consolidation, Attention and Subjective Experience
Patients have reported decreases in waist circumference, body mass index (BMI), and visceral fat, all of which are critical for reducing cardiovascular risk
